Search

Home > GRACEcast Lung Cancer Video > ALK Inhibitors for Acquired Resistance: Zykadia and Alectinib
Podcast: GRACEcast Lung Cancer Video
Episode:

ALK Inhibitors for Acquired Resistance: Zykadia and Alectinib
Category: Science & Medicine
Duration: 00:03:44
Publish Date: 2016-02-18 14:00:00
Description:

Dr. Nathan Pennell, Cleveland Clinic, discusses acquired resistance to Xalkori in ALK-positive patients, and second generation inhibitors designed to overcome that resistance, such as Zykadia and alectinib.
Total Play: 0